Upgrade to SI Premium - Free Trial

Needham Reiterates Buy Rating on Medtronic, Inc. (MDT)

March 13, 2026 6:32 AM
Needham analyst Michael Matson reiterated a Buy rating and $120.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented: "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments